
usd feb pm et
summari compani provid diagnost test inform servic physician hospit
manag care organ employ govern agenc
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
oct pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
lift target price base
ratio ep estim
reflect slight premium peer
narrow ep estim
start ep estim
close ep
vs beat capit iq
consensu estim driven strong
volum growth exclud
acquisit expand health plan
network access partial off-set
adjust oper margin improv
due volum growth
on-going product improv
expect approxim revenu growth
pressur relat protect access
expens due tighten labor market
industri /paig meyer
risk assess reflect leadership posit
larg matur diagnost test industri
compani broad geograph servic area divers
balanc custom mix grow recognit
import signific diagnost test
think regulatori uncertainti creat risk
apr ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview lead independ clinic lab oper offer
broad rang clinic laboratori test servic use physician detect diagnosi
treatment diseas medic condit test rang routin blood cholesterol
test highli complex esoter test gene-bas test molecular diagnost test
end network princip laboratori throughout number smaller
rapid respons stat laboratori patient servic center along facil
mexico puerto rico england
process approxim million requisit physician test request
million routin test gener net sale gene-bas esoter test
gener net sale anatom patholog test servic account net sale
diagnost solut account remain net sale routin test measur import health
paramet function kidney heart liver thyroid organ esoter test
perform less frequent routin test and/or requir sophist equip materi
profession hands-on attent highli skill personnel result gener price
substanti higher routin test
corpor strategi one largest compani see matur market
limit growth potenti forese annual industri sale growth low-singl digit dgx strategi
last updat novemb two key focal point acceler growth drive oper
excel aim acceler growth accret strateg acquisit partnership
integr deliveri network idn provis broad access diagnost innov achiev
recognit consumer-friendli provid diagnost inform servic support popul
health initi key theme drive oper excel includ reduct denial
patienc concess standard autom digit custom experi
protect access medicar act pama reimburs test price cut
maximum clf clinic laboratori fee
schedul reimburs rate cut maximum amount
disproportion affect small lab financi pressur lab attract acquisit opportun
think opportunist lab acquisit key driver growth next
year organ growth could achiev increas number higher-pr esoter test offer
achiev higher test volum
competit landscap clinic lab industri highli competit fragment thousand
independ clinic lab physician offic lab hospital-bas lab largest provid
lab servic thu enjoy signific economi scale competitor main competitor
publicly-trad laboratori corpor america lh
financi trend sale decreas billion repres five-year compound
annual growth rate compound-annual-growth-rate impact sustain pressur reimburs rate adjust
ep expand repres five-year compound-annual-growth-rate dgx debt level moder
net debt total capit leverag debt trailing-twelve-month ebitda
concern compani free cash flow million million
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
fairli valu
bullish sinc januari technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
outlook health care servic
sub-industri next year neutral
think rise wage increas
low unemploy
support stabl growth demand health care
low septemb
remain near recent month even
econom condit weaken
grow possibl expect demand
health care servic remain steadi rel
mani industri
import health care consum
hand see threat headwind
profit health care servic
industri rise wage pressur labor
shortag reimburs pressur
rise health care spend incent
legisl regul find way
control cost health care servic
industri easi target cost
cut exampl initi lower
chang payment model dialysi treatment
recent bipartisan effort tackl surpris
bill unclear chang
dialysi payment affect firm like davita
long-run forecast surpris
bill legisl like hurt physician
outsourc group limit
time see opportun
health care servic firm make best
recent headwind exampl major pbm
merg major insur off-set
pressur notabl
acquir aetna aet ci acquir
express script esrx anoth exampl
opportun evid lab servic firm
respons continu signific
provid opportun acquir
smaller lab gain scale smaller
lab like falter diminish
also see risk investor sentiment
relat certain headlin discuss
medicar type health care
system fade among democrat
candid think could still
talk point elect
would hurt investor sentiment even
littl chanc becom realiti
next sever year think realiti
would hurt health care servic
would like lead lower averag
struck individu mandat
associ afford act
howev court avoid determin
much remain valid think
outcom remov possibl
worst-cas scenario health care servic
firm complet
gener benefit increas
insur coverag past sever year
elimin certain provis
could hurt industri howev
opinion unlik case
anticip industri ep growth
estim growth rate
 health
servic gain vs increas
 health servic index
increas vs decreas
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
incorpor maintain price target base
ratio ep estim multipl near
low-end five-year rang expect sustain reimburs
pressur ep vs lower estim lower
ep initi ep net revenu
declin year-over-year billion declin revenu
per requisit mitig posit effect increas requisit
volum volum growth aid basi point acquisit expect
continu boost test volum acquisit struggl small
independ hospit laboratori pama-induc reimburs pressur
continu drive test price lower like main competitor laboratori corpor
lh aim drive growth partnership hospit health
system feel financi pressur /kevin huang cfa
et cfra rais opinion share quest diagnost
hold sell maintain price target
base ep estim announc
releas novemb lower revenu earn
outlook guid investor toward adjust ep greater
vs previou rang lower ep outlook primarili
due increas reserv associ revenu account receiv
previous highlight elev account receiv level
concern lower ep ep
report revenu expect billion vs
previou expect billion volum weak
driven hurrican michael california wildfir recent east
coast snowstorm lower revenu guidanc increas
reserv see less downsid share henc lift
opinion share hold /kevin huang cfa
analyst research note compani news
pm et cfra maintain hold opinion share
incorpor lift target price base
ratio ep estim reflect slight premium
peer narrow ep estim start
ep estim close ep vs
beat capit iq consensu estim driven
strong volum growth exclud acquisit expand
health plan network access partial off-set reimburs pressur
dgx adjust oper margin improv
due volum growth on-going product improv
expect approxim revenu growth despit signific
reimburs pressur relat protect access medicar act
also anticip rise wage expens due tighten labor market
pm et cfra maintain hold opinion share
incorpor maintain target price base
ratio ep estim multipl
slightli five-year averag forward price-to-earnings ratio reflect
industry-wid reimburs pressur ep vs beat
expect keep ep estim lift
ep estim share trade slightli today
compani provid full-year guidanc came light rel consensu
expect net revenu grew year-over-year billion
expect requisit volum grew organ off-set
partial declin revenu per requisit continu focu
deliv cost effici counter industri headwind sustain
reimburs pressur increas payer focu drive better valu
adjust oper margin improv
pm et cfra maintain hold opinion share inc
lift target price base ratio
ep estim multipl slightli
five-year averag forward price-to-earnings ratio reflect industry-wid
reimburs pressur ep vs exceed estim
lift ep estim net revenu
grew year-over-year billion despit loss sever
large-volum low-margin capit contract basi point impact
volum growth requisit volum growth acceler
organ revenu per requisit declin one
competitor offer rate said contract would unprofit
fortun non-renew contract expect
insignific impact top bottom line adjust oper
incom million reflect oper margin
/kevin huang cfa
et cfra maintain hold opinion share inc
rais price target base
ratio ep estim multipl
five-year averag forward price-to-earnings ratio expect sustain
reimburs pressur clinic laboratori compani ep vs
lower estim lift ep
ep net revenu rose
year-over-year billion affect increas requisit
volum declin revenu per requisit organ basi
requisit volum increas report volum growth aid
acquisit remind expect see million
industry-wid reimburs pressur although off-set
acceler volum growth work expand relationship
begin juli member prefer
pm et cfra reiter hold opinion share
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
